Literature DB >> 167232

Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.

R M Zakheim, L Mattioli, A Molteni, K B Mullis, J Bartley.   

Abstract

To test the hypothesis that the renin-angiotensin system is involved in the development of the pulmonary vascular patholigic changes of chronic alveolar hypoxia, two groups of rats were exposed to 0.5 atm. for 21 days. One group received SQ 20,881 (2 mg. per kg.) every 8 hours subcutaneously and the second group received normal saline. A third group of rats was maintained at normobaria. Rats receiving SQ 20,881 had significantly less pulmonary arterial hypertrophy and right ventricular hypertrophy than hypobaric animals. SQ 20,881-treated rats showed a significant increase in adrenal weight but a marked reduction in the thickness of the zona glomerulosa, as compared with the other groups. Our findings indicate that angiotensin II is necessary in the development of the pulmonary vascular structural changes of chronic alveolar hypoxia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167232

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  25 in total

1.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.

Authors:  Roy Emanuel; Astha Chichra; Nirav Patel; Thierry H Le Jemtel; Abhishek Jaiswal
Journal:  Ann Transl Med       Date:  2018-08

Review 3.  How valid are animal models to evaluate treatments for pulmonary hypertension?

Authors:  Maria E Campian; Maxim Hardziyenka; Martin C Michel; Hanno L Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09       Impact factor: 3.000

Review 4.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 5.  Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema?

Authors:  K F Whyte; D C Flenley
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

6.  Effects of captopril on pulmonary haemodynamics.

Authors:  C Richard; J L Ricome; A Rimailho; M Conrad; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Separate and combined use of verapamil, aspirin and captopril in experimental chronic pulmonary hypertension.

Authors:  D Kentera; D Susić; M Zdravković
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

8.  Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs.

Authors:  M A Miller; C A Hales
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Hypoxia and the neonatal rabbit lung: neuroendocrine cell numbers, 5-HT fluorescence intensity, and the relationship to arterial thickness.

Authors:  I M Keith; J A Will
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

10.  Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flow.

Authors:  B J Lipworth; K D Dagg
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.